{"id":"W2460337359","doi":"10.1007/s40261-016-0437-4","title":"Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers","year":2016,"lang":"en","type":"article","venue":"Clinical Drug Investigation","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"ca_institutions":"Western University","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Pharmacokinetics; Tolerability; Pharmacodynamics; Adverse effect; Placebo; Ulcerative colitis; Pharmacology; Area under the curve; Internal medicine; Gastroenterology; Cmax; Disease; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003997889,0.0003874362,0.0006082046,0.0001609934,0.0002831187,0.0003555088,0.0001506836,0.0004617588,0.001402033],"category_scores_gemma":[0.0009076418,0.0002952835,0.0002586214,0.0001319095,0.0004778112,0.0004291778,0.000118472,0.0008225192,0.0003970643],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001925507,"about_ca_system_score_gemma":0.0002476956,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001058751,"about_ca_topic_score_gemma":0.001140215,"domain_scores_codex":[0.9997843,0.00005938185,0.00001184852,0.00006572922,0.00003070231,0.00004810394],"domain_scores_gemma":[0.9997285,0.00006544721,0.00005269253,0.00003876717,0.00002647733,0.00008807793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4806958,0.01249872,0.03558976,0.0001999763,0.0003007407,0.0008655738,0.000989466,0.001169778,0.3459837,0.0001791014,0.001253047,0.1202744],"study_design_scores_gemma":[0.01670049,0.5078617,0.349908,0.00003659679,0.0006297424,0.001926895,0.0005219094,0.004701468,0.1143768,0.0003359776,0.002895398,0.000104977],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9989409,0.0002046556,0.0002515119,0.00001678295,0.00001213597,0.00007608112,0.00009904581,0.00002016453,0.0003786538],"genre_scores_gemma":[0.9985415,0.0001331371,0.0002654435,0.00005000586,0.00002314761,0.00006401583,0.0001612212,0.000008030834,0.0007536343],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001402033,"threshold_uncertainty_score":0.00469023,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02330174514583199,"score_gpt":0.3287272009553941,"score_spread":0.3054254558095622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}